v3.25.4
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Details) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
EPS Numerator      
Income from continuing operations attributable to Pfizer Inc. common shareholders $ 7,745 $ 8,020 $ 2,134
Discontinued operations––net of tax 25 11 (15)
Net income attributable to Pfizer Inc. common shareholders 7,771 8,031 2,119
EPS Numerator––Diluted      
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions 7,745 8,020 2,134
Discontinued operations––net of tax 25 11 (15)
Net income attributable to Pfizer Inc. common shareholders and assumed conversions $ 7,771 $ 8,031 $ 2,119
EPS Denominator      
Weighted-average common shares outstanding––Basic (in shares) 5,683 5,664 5,643
Common-share equivalents (in shares) 31 36 66
Weighted-average common shares outstanding––Diluted (in shares) 5,713 5,700 5,709
Anti-dilutive common stock equivalents (in shares) [1] 11 24 9
[1] These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.